Clene Inc. Accounts Payable
Clene Inc. (CLNN) had Accounts Payable of $1.14 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $1.14M.
- 2026-03-31: Accounts Payable, Current $1.31M.
- 2025-12-31: Accounts Payable, Current $892.00K.
- 2025-09-30: Accounts Payable, Current $1.37M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.14M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.31M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $892.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.37M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $828.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.41M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $1.24M 10-K · filed 2026-03-17 |
| 2024-09-30 | $1.68M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.07M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.65M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.50M 10-K · filed 2025-03-24 |
| 2023-09-30 | $1.89M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $846.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $608.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.01M 10-K · filed 2024-03-13 |
| 2022-09-30 | $3.45M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $4.53M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.31M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.92M 10-K · filed 2023-03-13 |
| 2021-09-30 | $1.02M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $1.14M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $739.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.12M 10-K · filed 2022-03-11 |
| 2019-12-31 | $889.00K 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |